BRC researchers are exploring complex connections in the brain and spinal cord, and how they enable us to see, learn, remember, move, and adapt.
Our scientists and clinicians are developing new therapies designed to prevent, minimize and reverse neurological damage caused by injury and disease.
CIHR awards $3 million
Vascular pathology in traumatic brain injury
Dr. Alon Friedman and his team are investigating traumatic microvascular injury in the brain—and damage to the blood-brain barrier (BBB)—as potential biomarkers and therapeutic targets for long-term neurological and cognitive complications of traumatic brain injury.
Balwantray Chauhan, PhD, Ophthalmology & Visual Science
Changes in the retina and optic nerve in experimental glaucoma
Dr. Bal Chauhan and his team will use novel techniques and their CIHR funding to learn how retinal ganglion cells change and die in experimental models of glaucoma, and how this deterioration affects visual function.
Victor Rafuse, PhD, Medical Neuroscience
Synaptic dysfunction at the neuromuscular junction in ALS
Dr. Victor Rafuse and his team are shedding light on the mechanisms that cause motor neurons to withdraw from the neuromuscular junction in ALS.
Restoring useful function to denervated skeletal muscles
A second major CIHR project grant will allow Dr. Rafuse to continue to explore how the nervous system may be bypassed to stimulate muscle cells directly with light.
BRC GRANTS - CALL FOR SUBMISSIONS
All submission are due by MARCH 3rd
Click on links above for details.
RESI on MaRS Early Stage Investor Conference
The Redefining Early Stage Investments (RESI) on MaRS health investment series is the largest showcase of early stage health tech innovation in Canada with a focus on biotech, medical devices, digital health, and consumer health and wellness. The event features networking events, an exhibitor space, and keynote presentations and panels on the latest life science industry trends. Investors (Venture Capitals, Family offices, Angels), tech scouts of large corporations, buyers, foundations, and academic institutions seeking the latest health tech trends can use RESI’s comprehensive B2B platform to review profiles of other RESI conference participants and sschedule one-on-one and/or group B2B meetings.
February 10, 2017, Toronto, ON
Registration is open.
Brain Awareness Week 2017
March 13-17 2017
November 2-4, 2017, Toronto, ON
January 21, 2017, Toronto, ON
BRC awards grants to innovative projects
The Brain Repair Centre awarded grants to five BRC members in its most recent round of competitions:
Dr. Turgay Akay received the first-ever BRC Discovery Grant for his work to understand the mechanisms that drive the loss of neurons and motor function in ALS. Full story.
Dr. David Clarke received a BRC Knowledge Translation Grant to field test a mobile app that he and his collaborators have developed to help neurosurgery residents and nurses hone their knowledge and skills of surgical instruments and procedures. Full story.
Dr. Gail Eskes received a BRC Knowledge Translation Grant to transfer a computerized battery of tests for assessing attention from a PC to a mobile format. The new portable attention test will become a pivotal tool in the Cognitive Repair Kit for restoring attention and other cognitive functions following stroke. Full story.
Dr. George S. Robertson received a BRC Knowledge Translation Grant to test the neuroprotective effects of a new compound he has developed in collaboration with a Saskatoon-based R&D firm. Full story.
Dr. Johane Robitaille received a BRC Research, Dissemination and Commercialization (RD&C) Grant to help host the prestigious biennial meeting of the International Society for Genetic Eye Diseases and Retinoblastoma in Halifax in August 2015. Full story.